Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Manage a Patient with Hypertension, Diabetes, and
Chronic Kidney Disease

Manage a Patient with Hypertension, Diabetes, and Chronic Kidney Disease.

Abbreviated Prescribing Information

An overview of DUPIXENT

Хвороба Фабрі: погляд невролога та кардіолога

Під час даного вебінару експерти поділяться найновішими знаннями, клінічними кейсами та інноваційними підходами до діагностики й лікування хвороби Фабрі, а також особливостями менеджменту пацієнтів з даною патологією.

Laieninformation – Die Rolle der Betazelle

Laieninformation – Typ-1-Diabetes: Von unsichtbar zu unübersehbar-Broschüre

LIBERTY AD CHRONOS (18+ years)

LIBERTY AD CHRONOS was a randomized, double-blind, placebo-controlled trial in adults with 
moderate-to-severe atopic dermatitis

LIBERTY AD SOLO-CONTINUE (18+ years)

LIBERTY AD SOLO-CONTINUE was a randomized, double-blind, phase 3 clinical trial at 185 sites in North America, Europe, Asia, and Japan.

LIBERTY AD HAFT (12+)

LIBERTY AD HAFT was a randomized phase 3 trial in adults and adolescents with moderate-to-severe hand and foot atopic dermatitis inadequately controlled with topicals.

DUPIXENT delivers a high standard of efficacy in adults

Efficacy is shown through real-world evidence, skin bacterial microbiome, trans-epidermal water loss (TEWL), and nonatopic comorbidities.

Infant and young child data

Significant improvement in Worst Scratch and Itch NRS score, Skin Clearance, and Children’s Dermatology Life Quality Index (CDLQI).

DUPIXENT delivers a high standard of efficacy in children

Efficacy is shown through 3 years of disease control, impact on growth curve, and improvement in mental health.​

LIBERTY AD CHRONOS (18+ years)

LIBERTY AD CHRONOS was a randomized, double-blind, placebo-controlled trial in adults with 
moderate-to-severe atopic dermatitis